Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds SVB Leerink Maintains Underperform on Moderna, Raises Price Target to $77

SVB Leerink Maintains Underperform on Moderna, Raises Price Target to $77

SVB Leerink analyst Mani Foroohar maintains Moderna (NASDAQ:MRNA) with a Underperform and raises the price target from $70 to $77.

byBenzinga Newsdesk

August 1, 2022

1 minute read

SVB Leerink analyst Mani Foroohar maintains Moderna (NASDAQ:MRNA) with a Underperform and raises the price target from $70 to $77.

Analyst Ratings

7 Analysts Have This to Say About Owens-Corning

By Benzinga Insights

May 24, 10:02 AM

Owens-Corning (NYSE:OC) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

Biden Puts Airlines On Notice, Proposes Mandatory Compensation For Delays And Cancellations

By AJ Fabino

May 8, 3:08 PM

President Joe Biden and Transportation Secretary Pete Buttigieg announced a new proposal on Monday aimed at holding airlines accountable for controllable cancellations and delays.

AAL

MeiraGTx Announces $60M Private Placement Of 10.7M Ordinary Shares At A Price Of $5.75/Share

By Benzinga Newsdesk

May 3, 8:38 AM

MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it has agreed to sell approximately 10.7 million ordinary shares at a price of $5.75 per share.

MGTX